Verition Fund Management’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-740,911
Closed -$689K 2369
2023
Q3
$689K Buy
+740,911
New +$815K 0.01% 1264
2021
Q2
Sell
-383,748
Closed -$3.3M 1906
2021
Q1
$3.3M Buy
383,748
+259,083
+208% +$2.87M 0.04% 284
2020
Q4
$1.51M Buy
+124,665
New +$1.72M 0.01% 430
2020
Q3
Sell
-43,985
Closed -$661K 1087
2020
Q2
$661K Sell
43,985
-183,147
-81% -$2.47M 0.02% 524
2020
Q1
$1.65M Buy
+227,132
New +$1.78M 0.07% 194

Other funds holding CGEN

Verition Fund Management's CGEN Position: Q4 2023 in Review

Verition Fund Management sold out of Compugen (CGEN) in Q4 2023, closing a stake of 740,911 shares — an estimated $689K sold.

Verition Fund Management first reported a position in CGEN in Q1 2020 and held it in 5 quarters. The position peaked at $3.3M in Q1 2021. 72 funds tracked by Wall St. Rank hold CGEN as of Q4 2023.

  • Verition Fund Management reported no remaining Compugen position as of Q4 2023 after selling out during the quarter.
  • Verition Fund Management sold 740,911 Compugen shares in Q4 2023, an estimated $689K.
  • Verition Fund Management first reported a position in Compugen in Q1 2020 and held it in 5 quarters.
  • Verition Fund Management's Compugen position peaked at $3.3M in Q1 2021.
  • 72 funds tracked by Wall St. Rank held Compugen as of Q4 2023.

Based on Verition Fund Management's 13F filing for Q4 2023, filed 14 Feb 2024.